Solutions And Solubility Flashcards
Extemporaneous formulation (example)
Thiamine (vitamin B1) HCL oral liquid
Medium therapeutic index
Moderate technical risk
Therefore a low to moderate risk extemporaneous preparation
Extemporaneous formulation (example) Clinical pharmaceutics
Drug should be in solution at all strengths (usually 20-100mg/ml)
pH sensitive: specification of ingredients should be checked prior to use
Stability depends on excipients
Optimising solubility (like dissolves like)
Acyclovir (aciclovir)
Max solubility in water at 25 degrees exceeds 100mg/ml
At physiological ph acyclovir will exist as unionised form (Mr 225) and a max solubility in water at 37 degrees of 2.5 mg/ml
pH affects solubility and the salt form
What are the pKas of acyclovir
2.27 and 9.25
What is the ClogP of acyclovir
-0.95
4 types of solutions
Oral solution
Oral elixirs (contain ethyl various alcohols as co solvent. Phenobarbital elixir, 10% v/v propylene glycol, 20% v/v ethyl alcohol)
Oral syrups (ca. 85% sugars)
Others eg mouthwashes, gargles, rectal solutions and enemas
Define pharmaceutical oral solutions
Liquid preparations in which the therapeutic agent and the various excipients are dissolved in the chosen solvent system
Advantages of oral solutions
Ease of use (children or elderly)
Drug is dissolved and readily available for absorption (as long as the drug is soluble at stomach/GI pH it will have a greater bioavailability than solid oral dosage forms
Modification of taste can improve compliance of bitter tasting drugs
Disadvantages of oral solutions
Stability - can’t be used for drugs unstable in water e.g. Aspirin
Limited by the solubility of some drugs
Expensive to transport compared to some other dosage forms (adds to overall cost)
Bulky for patients to carry with them
Common excipients
Flavours and colours - sweeteners,dyes, etc.
Preservatives including antioxidants
Vehicle - usually purified water
Co solvents A ethanol, propylene glycol, glycerin
Solubility enhancing agents - ie surfactants
Viscosity modifiers
Buffers
Removal of a molecule or an atom from the solid state
Formation of a cavity within the solvent - energetically unfavourable as disorder in the matrix increases and there are fewer solvent-solvent interactions
Solute separation from bulk solute - solute-solute interactions are unfavourable but it is entropically viable
Accommodation of the drug molecule into the cavity - the results of favoured solvent-solute interactions which are similar to solvent-solvent interactions (like dissolves like e.g. Polarity)
Drug solubility and dissolution
Involved endothermic processes (requires absorption of heat, breakage of solute-solute and solvent-solvent bonds, formation of solute-solvent bonds)
May liberate energy: dissolution occurs when the Gibbs free energy is negative
Legal requirements of drug solubility
Drugs and excipients of a solution must be and remain in solution throughout the shelf life of the product
Products are homogenous (uniform)
What causes changes in solubility
Changes in pH and or temperature presents challenges to maintaining homogeneity
Solubility at the selected pH may be
High - stable, easy to formulate
Moderate - maybe be pH sensitive for example consider using solubility enhancers as co solvents, buffers or surfactants
Low - co solvents and similar approaches do not exchange solubility sufficiently, consider alternative formulations such as suspensions